Inventor · disambiguated record
Yi Ding
Also filed as: DING YI · DING YI-CHUN
7 granted patents·15 pending applications·16 citations·filing 2004–2025
77Inventor score
Files withFIRMENICH & CIE7CHENGDU HUITAI BIOMEDICINE CO LTD3GALAXY BIOTECH LLC3HARBOUR BIOMED SHANGHAI CO LTD3BEIJING XUANYI PHARMASCIENCES CO LTD1
Top patents by PatentIndex Score
22 records- 0185US9486434B2Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancerZHANG YUESHENG·Filed 2012·Granted Nov 8, 2016·12 cites·6 claims
- 0282US12428479B2CLDN18.2-targeting antibody, bispecific antibody and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Granted Sep 30, 2025·1 cites·17 claims
- 0378US10941204B2Highly potent antibodies binding to death receptor 4GALAXY BIOTECH LLC·Filed 2016·Granted Mar 9, 2021·1 cites·11 claims
- 0476US11485782B2Anti-claudin 18.2 antibodiesBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2019·Granted Nov 1, 2022·2 cites·16 claims
- 0570US2025312394A1Lacticaseibacillus Rhamnosus DY801 and Application ThereofNANFANG HOSPITAL SOUTHERN MEDICAL UNIV·Filed 2024·Application pending·0 cites
- 0667US11891446B2Highly potent antibodies binding to death receptor 5GALAXY BIOTECH LLC·Filed 2021·Granted Feb 6, 2024·0 cites·11 claims
- 0767US2025098720A1Sweetener compositionsFIRMENICH & CIE·Filed 2023·Application pending·0 cites
- 0864US2025145581A1Purification process for polymethoxylated flavonoids and compositions obtained therefromFIRMENICH & CIE·Filed 2023·Application pending·0 cites
- 0962US2024237690A1Licorice Compounds and Their Use as Flavor ModifiersFIRMENICH & CIE·Filed 2022·Application pending·0 cites
- 1062US2024164422A1Flavoring compositionsFIRMENICH & CIE·Filed 2022·Application pending·0 cites
- 1162US2025340631A1Cldn18.2-targeting antibody, bispecific antibody and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 1261US2024099344A1Hydroxy- and methoxy-substituted flavonoids and their useFIRMENICH & CIE·Filed 2022·Application pending·0 cites
- 1361US2025388623A1Peptide inhibitor and use thereofCHENGDU BRILLIANT INSPIRATION BIOTHERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 1461US2024390450A1Polypeptide, polypeptide fragment, derivative thereof, and applications thereofCHENGDU HUITAI BIOMEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 1559US2023329299A1Malonyl steviol glycosides and their comestible useFIRMENICH & CIE·Filed 2021·Application pending·0 cites
- 1656US2025136694A1Anti-b7-h4 antibody, and preparation method therefor and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1755US12378299B2CD80 variant proteins and uses thereofXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·10 claims
- 1855US2025331542A1Sweetener compositionsFIRMENICH & CIE·Filed 2023·Application pending·0 cites
- 1951US2005220781A1IFIX, a novel HIN-200 protein, for cancer therapyYAN DUEN-HWA·Filed 2004·Application pending·0 cites
- 2048US12011475B2Polypeptide, polypeptide fragment, derivative thereof, and applications thereofCHENGDU HUITAI BIOMEDICINE CO LTD·Filed 2018·Granted Jun 18, 2024·0 cites·6 claims
- 2139US2022280594A1Application of polypeptide or derivative thereofCHENGDU HUITAI BIOMEDICINE CO LTD·Filed 2020·Application pending·0 cites
- 2237US2019352386A1Highly potent monoclonal antibodies to angiogenic factorsGALAXY BIOTECH LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yi Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →